Abstract: Vanadium compounds are characterised by a broad spectrum of action in vivo and in vitro. Their insulin-mimetic activity is manifested in their ability to normalize changes observed in both clinical and experimental diabetes (i.e. hyperglycaemia, hyperlipidaemia, lowered cell sensitivity to insulin) through the regulation of carbohydrate and lipid metabolism and the removal of secondary symptoms of this disease (as e.g. retinopathy, cardiomyopathy, nephropathy). Nevertheless, vanadium is considered to be a toxic element in both cationic and anionic form, although the latter type has more serious side effects. This is accounted for by the faster absorption of anionic forms, although the chemical structure, geometry, and the manner of synthesis of its derivatives also contributes to this elevated toxicity. Besides their antidiabetic properties, vanadium derivatives have also been observed to influence processes related to mitogenic cell responses (apoptosis, proliferation, neoplastic transformation). However, both anti-and pro-neoplastic properties of vanadium are reported.
Inroduction
Vanadium is an element from the transition metal group of the periodic table, which oxidation states range from (-III) to (+V), although the most stable oxidation of vanadium is (+IV) [1, 2] . As a result of its more frequent occurrence in the environment, it is absorbed by plants and travels along the food chain into the body of animals and humans. However, while the concentration of vanadium ranges from 10 to 360 mg/kg in the soil, from 1 to 30 µg/l in water, and from 6 to 1320 ng/m 3 in the air, its content is as low as about 10 µg/kg in food and 5-20 nM in animal and human tissues [3] . As in the case of many other elements, small amounts of vanadium are beneficial to the growth and development of animals and, according to the suggestion of Nilsen and Uthus [4] , also human body, although there is no strong evidence that vanadium is an essential trace element for human. Its deficiency in mammals inhibits growth, impairs the generative functions, thyroid metabolism and bone mineralization, and disturbs the lipid and carbohydrate balance. Hence, vanadium is a necessary ingredient of the daily diet [1, 5, 6] . However, the daily demand for that element is about 10 µg in humans, while the actual consumption is estimated at 10-60 µg depending on individual diet. On the other hand, larger doses taken as a variety of compounds are toxic and noxious, causing irritation of the eyes and mucous membranes of the upper respiratory duct, coughing, fatigue and depression.
The overall metabolism of vanadium
The overall metabolism of vanadium in the human body has not been fully evaluated yet. What we do know is that water-soluble salts of that element mainly reach the body via the alimentary canal, while V 2 O 5 is absorbed well from the respiratory system [3, 7, 8] . Probably just 5-10 % of vanadium contained in food is actually retained in the animal and human body, with the amount absorbed depending on the physico-chemical properties, concentration and manner of administration of its derivatives. Nevertheless, vanadium compounds are characterised by low absorption from the alimentary system, which reduces their negative effects. Blood levels of this element 30 minutes after administration are 6-7 times lower in the case of gastric and subcutaneous absorption compared to blood levels resulting from peritoneal and tracheal administration. In the stomach, most vanadium complexes are transformed into the cationic (vanadyl) form and then absorbed through the duodenal mucous membrane into blood, where 90% is bound by transferrin or albumin. These proteins stabilize vanadyl ions, which are spontaneously oxidised into vanadate ions, which are the anionic form also found in the stomach and intestine, where they permeate the blood through the anion channel to be bound by transferrin. Both ion types are immediately distributed throughout the body, and half of the entire "bound" vanadium pool is accumulated mainly in the bones, liver, spleen and kidneys. Homeostatic mechanisms regulate the absorption of this element, systematically removing it from the blood stream as well as cells, inside which the concentration rarely exceeds 0.2 µM and only rises to 10-20 µM in animals and 1-5 µM in humans at the moment of administration of vanadium [9] [10] [11] . This amount is excreted with urine or through bile with faeces, with the ratio of vanadium excreted with urine to that excreted with faeces being 5:1. The biological half-life of vanadium in the human body is approximately 42 days, but the greatest amount of the element is removed within 2 days of the intake [3] .
3 Intracellular transport of vanadium and its influence on the synthesis of secondary signalling transmitters
The transport of vanadium ions through membranes has also not been fully elucidated.
Vanadyl compounds have been found to penetrate the erythrocyte membranes through passive diffusion. Their interaction with membranes stabilizes the complexes and stimulates conformational changes of its proteins, although the process of spontaneous oxidation of cationic to anionic ions is also observed [12] . Vanadate compounds penetrate the cells through anionic channels, where they are reduced to the vanadyl form. Further experiments using CaCo-2 cells (the neoplastic line of the colon cells) have shown that vanadium in the cationic and anionic forms penetrates the intracellular space by means of passive diffusion causing changes in the cellular microvilli and the structure of the actinic filament network [13] . However, experiments using the 48 V isotope have demonstrated intracellular distributions of vanadium mainly in the nucleus and mitochondria [14] . After penetration, vanadate ions undergo the oxidation-reduction processes, with participation of e.g. reduced glutathione, catechol, NADPH, NADH, cysteine, ascorbic acid and glutathione reductase. The form in which vanadium is found inside the cell depends on the quantitative ratio of the entire pool of reducers to metabolic oxidizers and also on the concentration of vanadium itself.
The vanadyl ion, i.e. VO 2+ , shows high reactivity in vitro, which is why it only occurs in the unbound form up to the concentration of 10 −7 mol/dm 3 , reacting with the available ligands and forming permanent complexes if the concentration is higher [15] . In the reactions with ADP and ATP, it forms junctions of the AMPV type (instead of ADP), as well as AMPV 2 or ADPV as analogues of ATP, but also with GDP, glutathione, amino acids (especially glutamine acid, cysteine and glutamine) and with nucleic acids and lipids [10] .
In contrast, vanadate ions form not only monomers (HVO ). Their ratio depends mainly on the pH value of the intracellular environment: in the neutral pH, for example, there is a rapid polymerization of monomers to hexamers, while dekamers emerge in acidic pH [16] . The polymers of vanadate ions form complexes with proteins, and can therefore influence the cell metabolism [17, 18] . For example, VO 4 -may replace it in the active centres of the enzymes to which also other phosphorus esters can bind triggering their activation or inactivation. Dimers and tetramers actively influence the process of polymerization of microtubules, while dekamers noticeably inhibit that process, and the mechanism of this action involves not only direct interaction with tubulin, but also inhibits the binding of MAP and Tau proteins to microtubules.
The oxidation state of vanadium is the factor that determines its extensive biological effects that are manifested not only in the regulation of activity of many enzymes, but also in the free radical processes and in phosphorylation/dephosphorylation of proteins. Nowadays these processes are investigated intensively, especially due to their crucial role in the cell proliferation, differentiation and the regulation of cell metabolism. The comprehensive action of vanadium ions through generation of reactive oxygen species in Fenton and Haber-Weiss reactions ( Fig. 1 ) results in the peroxidation of lipids of biological membranes and lipoproteins, which leads to the aggregation of proteins, the stiffening of membranes, activation of the mutagenic DNA processes (chromosome aberration, oxidation of guanine residues, formation of DNA-protein cross-links), degradation of the DNA, and the induction of apoptosis [19, 20] .
The induction or inhibition of neoplastic growth, stimulation of apoptosis or antiapoptotic action, activation or inhibition of the regulator genes of the cellular cycle or metabolic transformations, are all related to the processes of phosphorylation and dephosphorylation of kinases and phosphatases, which in turn are regulated by the action of vanadium ions [21] [22] [23] . Their influence on these enzymes results from the ability of vanadium complexes to mimic an analogue of the transient state, which can be either reversible (in the case of vanadate forms) or irreversible (in the case of peroxovanadic complexes) with cysteine residues of the protein tyrosine phosphatases. Fig. 1 Potential vanadium-induced cellular oxidative stress (see [16, 21] ); SOD -superoxide dysmutase.
Intensive research into the molecular mechanism of vanadium action started late, when the inhibition of Na + /K + ATPase was observed [24] (Fig. 2) . It was then found that other enzymes, such as Ca 2+ ATPase, are also inhibited by vanadium compounds [25] [26] [27] . Further research showed that vanadium can regulate the activity of secondary transmitters, for example, through stimulation of adenyl cyclase which catalyzes the reaction of ATP to cAMP transformation [28] . Today we know that vanadium, through stimulation of the membrane insulin receptor, also activates phospholipase C, which in turn catalyzes the hydrolysis of phosphatidilinositol-4,5-diphosphate (PI-4,5-P 2 ) into inositol-1,4,5-triphosphate (IP 3 ) and diacyloglycerol (DAG) [29] . The reports on the mechanism of action of vanadium are also significantly supplemented with reports on its direct impact on the type A, B, and C type protein kinases and on activation of the JAK/STAT track initiated by inhibition of protein tyrosine phosphatases [30] [31] [32] [33] . 
Vanadium compounds as antidiabetic factor
Diabetes (diabetes mellitus) is a chronic disease that affects about 140 million people in the world. Although the notion "diabetes" means a number of diseases that differ from one to another in terms of etiology, pathology and clinical course, their common feature is impairment of the metabolism of carbohydrates and lipids [34, 35] . Generally speaking, diabetes in humans is divided into so-called type 1 (IDDM, insulin-dependent) and type 2 diabetes (NIDDM, non-insulin-dependent). Type 1 diabetes results mainly from autoimmunological destruction of β cells of the pancreas, whereas type 2 is much more divergent etiologically and clinically, where β cells of the pancreas become insensitive to glucose stimulation yet continue to respond to other substances that stimulate insulin secretion, although insulin-resistance and defective insulin secretion is found in a high proportion of patients.
Despite many years of research and successes in the treatment of diabetes, the molecular mechanism of the disease and its accompanying subcellular changes have not been fully elucidated. Treatment aimed at controlling the metabolic changes that accompany the disease consist mainly of providing an adequate diet combined with the prescription of insulin or oral hypoglycaemic drugs, which unfortunately provides insufficient control of the physiological parameters [34, 36] . Hence, research is being carried out into less invasive and more effective methods of treatment than multiple insulin injections or its continuous subcutaneous pumping. Compounds are sought that might be administered orally, as diabetes is among the social diseases that show an upwards trend in the human population. The number of patients is estimated to rise to over 300 million by 2025, making diabetes the second most frequent cause of death after cancer [34] .
As was revealed during the last twenty years of research, vanadium compounds have been shown to act similarly to insulin on selected physiological and biochemical symptoms of both model diabetes (in tests on animals) and that found in humans [37, 38] . It is suggested that the broad spectrum of their antidiabetic action in vivo stems from their ability to influence the activity of enzymes of carbohydrates, lipid and protein metabolism, as well as processes that control the expression of the crucial genes involved in these pathways (Tab. 1). Their antidiabetic function is not thought to result from the protection of the ß cells of the pancreas [39] . There are, however, findings that deny such suggestions and indicate that vanadium may regenerate the pancreatic β cells in diabetic animals [40] . Thus, elucidation of this issue requires further experiments. Besides, information about the insulin-mimetic activity of vanadium derivatives is also provided by findings of in vitro research confirming their comprehensive and heterogeneous actions observed in vivo (Tab. 2).
The antidiabetic properties of vanadium, first described by Heyliger et al. [41] , led to the growth in the number of experiments using mainly VOSO 4 , Na 3 VO 4 and NaVO 3 as potential antidiabetic drugs. They were even administered orally to volunteers with type 1 and type 2 diabetes in USA and Canada [42] [43] [44] . However, a weaker action in humans was observed, compared to that of experimental animals. This resulted from the application of smaller doses of vanadium (lower blood concentration, shorter time of action). Another difference is the sensitivity of humans vs. animals to administered derivatives. In rodents, the dose that normalizes the blood glucose level is about 100 mg V/kg/day, while the same effect was observed in humans at a dose of 1.5 mg V/kg/day; under these conditions, the blood level of vanadium ranges from 10 to 20 µM in animals and from 1 to 5 µM in humans [10] . It should also be stressed that vanadium compounds are poorly absorbed from the alimentary duct and cause side effects, which is why current studies are investigating the synthesis of new organic and inorganic vanadium derivatives with better physico-chemical and thus also physiological and therapeutic parameters [45, 46] . This is confirmed by reports on the 2 nd stage of clinical research of vanadium derivatives as a group of KP-102 compounds, where favourable responses have again been observed in patients with both type 1 and type 2 diabetes [47] .
Antidiabetic activities of vanadium References
• normalization of the blood-glucose level through:
[10] => enhancing glucose transport to cells => stimulation of glucose oxidation and glycogen synthesis => stimulation of glicolysis and inhibition of gluconeogenesis => increasing sensitivity to insulin • normalization of the lipid metabolism through:
[10] => inhibition of lipolysis and stimulation of lipogenesis => decreasing triglyceride and cholesterol level in blood • normalization of bile acids alteration [10] • normalization of protein and amino acid metabolism
[10] • normalization of thyroid hormone level [9] • normalization of secondary diabetic complications through:
[9] => decreasing protein level in urine and urea/creatinine in blood => preventing histopathological changes in kidneys and cardiomyopathy/retinopathy => preventing ketoacidosis Table 2 In vitro antidiabetic activities of vanadium.
Mechanism of action
The mechanism of vanadium action is still poorly understood. Research carried out by several groups [51] [52] [53] suggests that in vitro, this element acts as an insulin mimetic and in vivo, as an insulin enhancer. There are three conceptions of the antidiabetic action of vanadium in vitro (Fig. 3) , although they do not explain all possible aspects of its insulin-like action:
(1) Mechanism related to activation by vanadate ions and vanadium oxides of the β subunit of insulin receptor (InsR), that is its cytoplasmic domain with tyrosine kinase activity. It differs from insulin mechanism of action in that only the tyrosine residues are subjected to phosphorylation [54] [55] [56] [57] . Insulin, however, also stimulates the phosphorylation of the serine and threonine residues located on the β subunit. Moreover, vanadium increases the number of InsR receptors and inhibits the degradation of the ligand-receptor complexes in the lysosomes of various cell types. This, among other things, accounts for the differences in inducing diabetic changes by the two particles. (2) Mechanism related to activation (by vanadyl and vanadate ions) of membrane tyrosine kinase (i.e. Memb PTK), non-glycosylated protein of 55 kDa located in the plasma membranes, which is not part of the insulin receptor [57, 58] . Memb PTK stimulates 3-phosphatidylinositol kinase (PI-3 kinase) irrespective of the activation of the tyrosine kinase receptor; while activation with (+IV) ions facilitates the glucose uptake and inhibits lypolysis, activation with (+V) ions enhances the metabolism of glucose and lipids. (3) Mechanism related to activation of cytosol tyrosine kinase (i.e. Cyt PTK) of 53 kDa mass, the InsR-independent activation of which by vanadate ions in the presence of Co 2+ and Mn 2+ lowers cell resistance to insulin, intensifies glucose oxidation, contributes to cell pH changes, regulates the concentration of Ca 2+ ions, and activates MAP proteins. This alternative pathway of signal transduction proves that vanadium raises cell sensitivity to insulin, thereby enhancing the effectiveness of its own action [56] [57] [58] . There is also evidence that vanadium can act as an insulin enhancer, as vanadiuminduced effects are dependent on residual endogenous insulin [53, 59] . It was shown that at least small doses of insulin are required to effect the action of vanadium in vivo, and in thereby restore normal blood sugar levels. There are two possible mechanisms underlying this effect: (1) Vanadium influences PTPase or non-receptor protein tyrosine kinase activities and enhances signal transduction pathways (independent on PI-3 kinase) interfering with cAMP level/action, which involve e.g. G protein, adenyl cyclase, PDE or PKA. This possibility could explain a key role that vanadium plays in liopolysis and gluconeogenesis. (2) Direct or indirect (through signal transduction pathway) effect on transcription and post-transcriptional processes, which are involved in metabolism of glucose and lipids. The mechanism of vanadium action still remains to be investigated. The lack of a universal mechanism of vanadium action stems from its different influences on various cellular processes. For example, vanadium derivatives act as generators of free radicals, regulators of kinase and phosphatase activity, and influence not only the metabolism of carbohydrates and lipids, but also cellular processes such as gene expression, immunological response, apoptosis, and cancerogenesis. Fig. 3 Targets of vanadium action [see [10, 54] ; InsR -insulin receptor; Memb PTK -membrane-bound non-receptor protein tyrosine kinase; Cyt PTK -cytosolic protein tyrosine kinase; PTK IR -β subunit of insulin receptor; PKB -protein kinase B; PI 3K -phosphatidylinosytol 3-kinase; PD K1 -phosphatidylinozytol dependent protein kinase 1; PTP -protein tyrosine phosphatase; GSK3 -glycogen syntase kinase 3; MAPK-MAPKKK -MAP kinases: ERK -extracellular signal-related kinase, JNK -c-jun N-terminal/stress activated protein kinase, p38 -p38 kinase; AP-1, NF-κB -transcription factors, MAP, Tau -cytoskeleton proteins; GLUT -glucose transporter; CM -cell membrane.
Toxicity of vanadium
The possibility of using vanadium derivatives as potential therapeutic factors triggered investigations on their probable side effects. There are many divergent data resulting from the fact that biological activity of vanadium depends on factors such as: the type of the derivative, manner of its administration, dose, length of treatment, and also individual and species specific sensitivity to the administered compound. The toxicity of vanadium is correlated to its degree of oxidation (vanadyl < vanadate ion) and chemical form (organic < inorganic ligand) [16, 42] . This was demonstrated by experiments on animals, mainly in rats and mice [9, 42, [60] [61] [62] . Its appears that both short-term (for a few days) and longterm (for a few months) administration of this element causes a variety of toxic effects such as hematological and biochemical changes (e.g. hemolysis and decrease in erythrocyte count/ hemoglobin level/hematocrit index, decrease in AST/ALT/LDH/ALP level), neurobehavioral injury (i.e. general activity and learning), abnormalities in development and reproduction (e.g. embryotoxicity, teratogenicity) or morphological and functional lesions in liver, kidneys, bones, spleen and leukocytes. Moreover, the most often observed side effects include loss of appetite and significant reduction of body weight, (often leading to anorexia), weakness and nose bleeding, vomiting, diarrhoea, dehydration, pulmonary hemorrhage or death. However, it was also reported, that long-term (for 5-12 months) administration of vanadium did not exert hematological, biochemical or histopathological effects [63] , and even lowered blood pressure and elevated plasma insulin levels in spontaneously hypertensive rats [64] .
Little is known so far about vanadium toxicity in humans. The findings show that short-term administration of vanadium derivatives (for the maximum of 4 weeks) to patients with diabetes and coronary disease causes slight gastric perturbations, while prolonged administration for about 5 months leads to anorexia, weight loss and abdominal pain [42, 65] . However, Fawcett et al. [66] observed no changes of either the blood cell count or the biochemical parameters and function of the liver and kidneys in their three month tests of athletes. There are still not enough experiments providing information about the effects of prolonged administration of vanadium derivatives to humans.
The treatment with vanadium compounds involves their incessant administration, and the accumulation of derivatives in tissues and the accompanying side effects may appear to be a real problem. This is why experiments that involved the administration of vanadium compounds with chelate forming factors have been carried out. The results of these experiments showed that the most effective factors were deferoxamine and tiron, which actively reduced the vanadium concentration in the kidneys, bones and liver, which are the areas of greatest vanadium accumulation. These diminished vanadium levels are achieved through its increased excretion in urine. These chelating agents reduce the risk of side effects without impairing of the therapeutic effects [62, 67, 68] . New derivatives with increased specificity of action and reduced toxicity compared to those applied before have also been synthesised. These compounds have the most stable chemical form in water solutions, which extends their efficiency and effectiveness of action [69, 70] .
Pro-and anticancer properties of vanadium
Besides the antidiabetic action, vanadium derivatives show pro-and anti-neoplastic action in vivo and in vitro. It is suggested that they might be used in chemotherapy due to their antiproliferative activity, cytostatic/cytotoxic activity (in apoptotic or necrotic way) and antimetastatic activity [16, 71, 72] . Parallel to reports on anticancer properties of vanadium derivatives, studies on their action in initiation and promotion of the neoplastic transformation have been reported [73, 74] . However, IARC (International Agency for Research on Cancer ) has not added vanadium and vanadium derivatives to its lists, which means that they have not been classified as cancerogenic factors. Although research is still in progress, so far it has failed to confirm vanadium ability to cause the neoplastic process in vivo [16, 75] . Instead, in vitro experiments have demonstrated that the accumulation of vanadium is more intense in neoplastic compared to normal cells, especially in the nucleus. This was proved e.g. for breast and colon cancer cells, leukaemia and melanoma, Ehrlich's ascites and lung carcinoma [16] .
In view of the reports on antitumor properties of vanadium, attempts have started at synthesis of organo-metallic vanadium complexes, so-called vanadocenes, where vanadium at (+IV) degree of oxidation is directly bound to organic ligand through the coal-metal bond. Further research showed that such complexes are characterised by anti-neoplastic activity through inhibition of the DNA and RNA synthesis in cells and/or generation of oxygen free radicals in those cells. However, at the same time, they are less toxic and better tolerated [76, 77] .
There are, however, experiments revealing mutagenic and pro-neoplastic properties of vanadium derivatives. For example, Shi et al. [78] suggested that induction of the neoplastic processes by metals (vanadium, arsenic, chromium) could activate the oxidation stress resulting from the presence of free oxygen radicals and the disturbed oxidationreduction balance of the body. The authors demonstrated the role of reduced glutathione and anti-oxidant enzymes, such as catalase and superoxide dismutase, in the processes of apoptosis, cell proliferation and differentiation, and as a consequence in neoplastic transformation. Other independent research teams also suggested this possibility, as well as the possibility that these compounds generate reactive forms of oxygen and nitrogen, which determines their cytotoxic properties [79, 80] .
The different and frequently opposing biological effects of organic and inorganic vanadium compounds depend on factors such as cell type, concentration, and in the case of organic complexes, the type of the ligand bound to the element (Tab. 3). As suggested by many researchers, the frequent opposing activities of vanadium compounds results from the specific conditions in the neoplastic cells (especially pH and the levels of free radicals) and from induction of different transduction pathways (through inactivation of the protein tyrosine phosphatases and/or activation of the protein tyrosine kinases) leading to translocation of i.e. NF-κB to the nucleus, and in consequence to transcription, apoptotic and lethal, or anti-apoptotic genes [16] . This lack of specificity reduces the applications of vanadium compounds in the complex system of the human body. Table 3 Some cytostatic and cytotoxic effects of vanadium compounds.
Hence, the relationship between the chemical and biochemical effects of vanadium derivatives and the different types of neoplastic cells on which they might selectively act is being studied. The mechanism of cytostatic and cytotoxic action of vanadium has not been fully explained yet. It is therefore difficult to identify causes of the direct and indirect toxicity effects of its derivatives in vitro. However, the impact of vanadium on the different pathways of intracellular signal transduction indicates that it is not universal [21, 81, 82] . The major contribution of the free oxygen radicals, direct (peroxidation of cell membranes and of organelle of e.g. mitochondria and lipoproteins of the plasma, damages of DNA and proteins, activation of microphages that excrete inflammatory cytokins) or indirect (induction of apoptosis/necrosis, neoplastic processes, expression of the key genes involved in initiation of the inflammatory state) is being stressed [83, 84] .
